ArticleWorld journal of microbiology & biotechnology2026
Integrative 16S rRNA characterization, pan-genome, and immunoinformatics approaches for the design of a multi-epitope vaccine against Bacillus cereus, a foodborne pathogen.
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bacillus cereus is a spore-forming foodborne pathogen responsible for diarrheal and emetic syndromes, as well as severe opportunistic infections. Its persistence in diverse environments and intrinsic resistance mechanisms highlight the urgent need for effective preventive strategies, particularly in the absence of licensed vaccines. In this study, an integrated computational and immunoinformatics approach was employed to identify conserved antigenic targets and design a multi-epitope vaccine candidate against Bacillus cereus. Pan-genome analysis enabled the identification of conserved antigenic proteins, followed by epitope prediction and construction of a multi-epitope vaccine. The designed construct exhibited strong antigenicity, stability, and solubility, with 97.3% of residues located in the favored regions of the Ramachandran plot and a ProSA-web Z-score within the range of native proteins. Molecular docking analysis demonstrated a favorable binding affinity for Toll-like receptor 2 (TLR2), while molecular dynamics simulations confirmed the structural stability of the complex. Codon optimization enhanced expression potential by reducing the GC content from 70.10% to 56.80%. Immune simulations predicted robust IgG responses, Th1-skewed cytokine production, and the development of immunological memory. Overall, the designed multi-epitope vaccine demonstrates strong in silico immunogenic potential, broad global population coverage (96.98%), and favorable expression feasibility. These findings support the proposed construct as a promising vaccine candidate; however, experimental validation through in vitro and in vivo studies is required to confirm its efficacy.
Indexed as
Identifiers
42154343What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.